TRIM-EDICINE
TRIM-edicine is an rapid growing, privately held biotechnology company engaged in the development of novel biopharmaceutical products for the treatment of unmet medical needs, including oral healthcare, dermal wounds, ischemia/reperfusion injury, sports medicine and muscular dystrophy. The company is built around a core of novel proteins with remarkable biological properties.
TRIM-EDICINE
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2008-01-01
Address:
Columbus, Ohio, United States
Country:
United States
Website Url:
http://www.trim-edicine.com
Total Employee:
1+
Status:
Active
Contact:
+1 614-487-3695
Email Addresses:
[email protected]
Total Funding:
2.85 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API WordPress Google Analytics LetsEncrypt Font Awesome Google Universal Analytics
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
ResoTher Pharma
ResoTher Pharma is a privately held biotechnology company
Sperm Check
Sperm Check, a privately held biotechnology company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
X-Chem
X-Chem, Inc. is a privately held biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.trim-edicine.com
- Host name: apache2-noxim.pdx1-shared-a2-12.dreamhost.com
- IP address: 69.163.185.136
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "TRIM-edicine"
TRIM-edicine - Crunchbase Company Profile & Funding
TRIM-edicine is an rapid growing, privately held biotechnology company engaged in the development of novel biopharmaceutical products for the treatment of unmet medical needs, …See details»
About - TRIM-edicine
TRIM-edicine is an rapid growing, privately held biotechnology company engaged in the development of novel biopharmaceutical products for the treatment of unmet medical needs, including oral healthcare, dermal wounds, …See details»
TRIM-edicine Company Profile 2024: Valuation, Funding
TRIM-edicine General Information Description. Developer of protein therapeutics designed for the treatment of human tissue. The company develops novel protein therapeutics and …See details»
MG53 (TRIM-edicine) - Drug Targets, Indications, Patents - Synapse
MG53 (TRIM-edicine), Initially developed by TRIM-edicine, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System Diseases,Skin and Musculoskeletal …See details»
TRIM-edicine, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TRIM-edicine, Inc. of Columbus, OH. Get the latest business insights from Dun & Bradstreet.See details»
TRIM-edicine Company Profile - Office Locations, Competitors
TRIM-edicine is a biotechnology company that develops biopharmaceutical products. It offers novel protein therapeutics for dermal wounds and reperfusion injury treatments, oral …See details»
TRIM-edicine - VentureRadar
TRIM-edicine is an rapid growing, privately held biotechnology company engaged in the development of novel biopharmaceutical products for the treatment of unmet medical needs, …See details»
TRIM-edicine joins Biotechnology Industry Organization (BIO), the ...
Apr 10, 2008 TRIM-edicine joins Biotechnology Industry Organization (BIO), the largest biotechnology organization in the world that is dedicated to representing the interests of …See details»
TRIM-edicine - Funding, Financials, Valuation & Investors
TRIM-edicine is an rapid growing, privately held biotechnology company. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ...See details»
TRIM-edicine, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore TRIM-edicine, Inc. with its drug pipeline, therapeutic area, technology platform, 11 literature, Disease Domain:Nervous System Diseases, Technology Platform:Recombinant …See details»
Trim-Edicine - Products, Competitors, Financials, Employees ...
Trim-Edicine is a biotechnology company specializing in regenerative medicine and therapy. Their main focus is on restoring cell health and resilience, with applications in treating cancers, rare …See details»
TRIM-edicine - Crunchbase
TRIM-edicine is an rapid growing, privately held biotechnology companySee details»
ATAP (Trim-edicine) - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 ATAP (Trim-edicine), Initially developed by TRIM-edicine, Inc., Now, its global highest R&D status is Pending, Therapeutic Areas: Neoplasms. Biomedical products. Data. …See details»
Leadership - TRIM-edicine
Dr. Jianjie Ma, Ph.D., is the Founder of TRIM-edicine. He holds the Karl P. Klassen Chair of Thoracic Surgery in the Department of Surgery at The Ohio State University (OSU). He is an …See details»
TRIM-edicine, Inc. - CAGE.report
Sep 2, 2016 TRIM-edicine, Inc. Trade Name ("Doing Business As ..."): DUNS Number: 803046676 Parent DUNS Number: Address, line 1: 1275 Kinnear Rd Address, line 2: City: ...See details»
TRIM-edicine - Contacts, Employees, Board Members
TRIM-edicine is an rapid growing, privately held biotechnology companySee details»
MG-29 - Drug Targets, Indications, Patents - Synapse
Last update 14 Nov 2024. MG-29. Last update 14 Nov 2024See details»
Recombinant human MG53 protein - TRIM-edicine - AdisInsight
TRIM-edicine is developing recombinant human Mitsugumin53 (MG53) protein for the treatment of muscular dystrophies and ischemia reperfusion. Other potential Recombinant human MG53 …See details»
Technology - TRIM-edicine
Through either the administration of recombinant MG53 protein or pharmacological modulation of endogenous MG53, TRIM-edicine believes it possesses a potentially important therapeutic …See details»